Post-prandial Glycemic Response to Fiber in Healthy Adults

August 16, 2017 updated by: Ingredion Incorporated

Post-prandial Glucose and Insulin Response to High-fiber Muffin Top Containing Resistant Starch in Healthy Adults

This randomized, double-blind, comparator controlled trial evaluated the blood glucose and insulin responses in healthy adults, after consuming a high fiber or low fiber muffin top.

Study Overview

Detailed Description

The fiber administered in this trial is a resistant starch type 4 derived from high-amylose maize starch. This product is high in dietary fiber (70% total dietary fiber (TDF), AOAC 2009.01 method) and can be used in a variety of bakery applications. The objective of this study was to evaluate the post-prandial blood glucose and insulin responses of healthy adults (n=28) after consuming a muffin top made with resistant starch or control muffin top, in a randomized, double-blind, crossover study. The muffin tops were matched for total weight, total carbohydrate, sugars, protein, and fat. During each 24-hour study period, subjects consumed a standard evening meal, fasted for 12 hours, and arrived at the study clinic the following morning. Serum glucose, serum insulin, and capillary glucose were measured after muffin top consumption. The subjects completed a seven day washout between treatments.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years of age or older,
  • BMI 18.0-29.9 kg/m2,
  • fasting glucose ≤ 6.0 mmol/L;
  • if female, not of childbearing potential (e.g. taking oral contraceptives, past hysterectomy)

Exclusion Criteria:

  • diagnosed metabolic or chronic diseases (e.g. type-2 diabetes);
  • cancer diagnosis or treatment within 5 years;
  • gastrointestinal problems;
  • bowel cleansing during prior week;
  • current medications to control blood glucose;
  • current medications to control blood cholesterol ;
  • current medications to control blood pressure;
  • smoker;
  • use of medical marijuana;
  • alcohol or drug abuse treatment in past 12 months;
  • allergy or sensitivity to study products;
  • blood donation in prior 2 months;
  • if female, currently pregnant, currently breastfeeding, or planning to become pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High fiber - low fiber
Treatment order described in arm title, resistant starch (high fiber muffin top) - conventional flour (low fiber muffin top)
Muffin top contained 11 g of fiber per portion
Muffin top contained 1 g of fiber per portion
Experimental: low fiber - high fiber
Treatment order described in arm title, conventional flour (low fiber muffin top)- resistant starch (high fiber muffin top)
Muffin top contained 11 g of fiber per portion
Muffin top contained 1 g of fiber per portion

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood glucose response
Time Frame: 0-4 hours after consumption
IV and capillary
0-4 hours after consumption

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood insulin response
Time Frame: 0-4 hours after consumption
IV
0-4 hours after consumption
Breath hydrogen response
Time Frame: 0-24 hours after consumption
Expired air
0-24 hours after consumption

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Tetyana Pelipyagina, MD, KGK Synergize

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 31, 2016

Primary Completion (Actual)

October 31, 2016

Study Completion (Actual)

October 31, 2016

Study Registration Dates

First Submitted

August 14, 2017

First Submitted That Met QC Criteria

August 14, 2017

First Posted (Actual)

August 17, 2017

Study Record Updates

Last Update Posted (Actual)

August 21, 2017

Last Update Submitted That Met QC Criteria

August 16, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 16AFHI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Glucose, Low Blood

Clinical Trials on resistant starch (high fiber muffin top)

Subscribe